Drug‐eluting stents versus bare‐metal stents for acute coronary syndrome
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Drug‐eluting Stents Versus Bare‐metal Stents for Acute Coronary Syndrome." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433897/all/Drug‐eluting_stents_versus_bare‐metal_stents_for_acute_coronary_syndrome.
Drug‐eluting stents versus bare‐metal stents for acute coronary syndrome. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433897/all/Drug‐eluting_stents_versus_bare‐metal_stents_for_acute_coronary_syndrome. Accessed December 14, 2024.
Drug‐eluting stents versus bare‐metal stents for acute coronary syndrome. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433897/all/Drug‐eluting_stents_versus_bare‐metal_stents_for_acute_coronary_syndrome
Drug‐eluting Stents Versus Bare‐metal Stents for Acute Coronary Syndrome [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 December 14]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433897/all/Drug‐eluting_stents_versus_bare‐metal_stents_for_acute_coronary_syndrome.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Drug‐eluting stents versus bare‐metal stents for acute coronary syndrome
ID - 433897
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433897/all/Drug‐eluting_stents_versus_bare‐metal_stents_for_acute_coronary_syndrome
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -